NIJS (Private limited company)

NIJS CV
BE 0442.650.887 Active ●Lierseveldstraat 27, 2560 Nijlen

NIJS is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0442.650.887. It was founded on 30-12-1990. Its registered office is in Nijlen. Its main activity is: Manufacture of basic pharmaceutical products and pharmaceutical preparations. Its annual accounts for 2025 report equity of € 306 627 and a loss of € 28 554. Addrly gives it a financial health grade of A, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for 3 of its last 4 financial years.

Information last updated on 07-10-2026.

Company information

Status
Active
Enterprise number
BE 0442.650.887
VAT registered
No
Founded
30-12-1990
Latest accounts
2025
Employees
-
Region
Flanders
Establishments
1
Filing record
On time 3 of 4 years
Peppol e-invoicing
Not registered
Registered office
Lierseveldstraat 27, 2560 Nijlen
Main activity
Manufacture of basic pharmaceutical products and pharmaceutical preparations
NACE activities
2110001 Etude, mise au point de la production des principes actifs destinés à la fabrication de médicaments
63100 Infrastructure informatique, traitement de données, hébergement et activités connexes
68201 Location et exploitation de biens immobiliers résidentiels propres ou loués, sauf logements sociaux
7739201 Location et location-bail de chapiteaux pour expositions, fêtes d'entreprises, concerts, etc, sans opérateur

Key figures of NIJS

202520242023
Profit / loss
iWhat the period earned after taxes. A negative amount is a loss.
€ -28 554+61 %€ -73 558€ 4 985
Equity
iWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company.
€ 306 627-9 %€ 335 181-18 %€ 408 738
Total assets
iEverything the company owns. Equal to total equity and liabilities, which says how it is financed.
€ 572 2320 %€ 573 672-19 %€ 709 116
Gross margin
iSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else.
€ 3 716-29 %€ 5 257-90 %€ 53 620
Employees (FTE)
iAverage number of workers over the period, in full-time equivalents.
---

Financial estimate

Financial health grade A, on a scale from A (safest) to E (most at risk)
Health barometer
The failure probability and the indicators behind this grade are visible with a free account.
Create a free account
Illustrative preview
Detected events
Appointments, capital, registered office, proceedings, extracted from the official acts.
Create a free account
Illustrative preview
Directors & mandates
3 mandates on record in the annual accounts.
Create a free account

Similar companies

Other companies in the same activity nearby.

CompanyTown
Janssen Pharmaceutica 2340 Beerse
PFIZER MANUFACTURING BELGIUM 2870 Puurs-Sint-Amands
Organon Heist 2220 Heist-op-den-Berg
Kaneka Belgium 2260 Westerlo
DE CEUSTER MESTSTOFFEN 2280 Grobbendonk
CAPSUGEL BELGIUM 2880 Bornem
MEDICA 2550 Kontich
Novartis Manufacturing 2870 Puurs-Sint-Amands
Looking for more information about NIJS?
The free plan gives you 20 complete company dossiers every month, no card required: health barometer, directors, company links and detected events.
Create a free account

Frequently asked questions

Is NIJS still active? Yes. The Crossroads Bank for Enterprises lists NIJS as active.

What is the VAT number of NIJS? NIJS is not registered for VAT. Its enterprise number is 0442.650.887.

When was NIJS founded? NIJS was founded on 30-12-1990.

What is the address of NIJS? The current registered office of NIJS is Lierseveldstraat 27, 2560 Nijlen.

When did NIJS last file annual accounts? The latest annual accounts of NIJS were filed on 13-07-2026.

Does NIJS file its annual accounts on time? NIJS filed its annual accounts within the legal deadline for 3 of its last 4 financial years. Late: 2024.

Is NIJS financially healthy? Addrly gives NIJS a financial health grade of A, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.

Is NIJS profitable? The annual accounts of NIJS for 2025 show a loss of € 28 554.

What is the equity of NIJS? The equity of NIJS was € 306 627 at the close of the 2025 financial year.

Who are the directors of NIJS? The annual accounts of NIJS record 3 mandates. The names, roles and dates are visible with a free account.

Can NIJS receive Peppol e-invoices? NIJS is not registered on the Peppol network at the moment.

What does NIJS do? The main activity of NIJS is: Manufacture of basic pharmaceutical products and pharmaceutical preparations.

Sources

How Addrly builds and refreshes this data